Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Collister JA. et al, (2024), Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 33, 812 - 820

Assessing the importance of primary care diagnoses in the UK Biobank.

Clifton L. et al, (2024), European journal of epidemiology, 39, 219 - 229

Where Medical Statistics Meets Artificial Intelligence. Reply.

Hunter DJ. and Holmes C., (2023), The New England journal of medicine, 389, 2403 - 2404

Where Medical Statistics Meets Artificial Intelligence.

Hunter DJ. and Holmes C., (2023), The New England journal of medicine, 389, 1211 - 1219

At Breaking Point or Already Broken? The National Health Service in the United Kingdom.

Hunter DJ., (2023), The New England journal of medicine, 389, 100 - 103

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.

Lopes Cardozo JMN. et al, (2023), Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41, 1849 - 1863

Load More